Your browser doesn't support javascript.
loading
Investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort study: methodology and cohort profile
Rilwan Azeez; Larisa Lotoski; Aimée Dubeau; Natalie Rodriguez; Myrtha E. Reyna; Tyler Freitas; Stephanie Goguen; Maria Medeleanu; Geoffrey L. Winsor; Fiona S. L. Brinkman; Emily E. Cameron; Leslie Roos; Elinor Simons; Theo J. Moraes; Puishkumar J. Mandhane; Stuart E. Turvey; Shelly Bolotin; Kim Wright; Deborah McNeil; David M. Patrick; Jared Bullard; Marc-André Langlois; Corey R. Arnold; Yannick Galipeau; Martin Pelchat; Natasha Doucas; Padmaja Subbarao; Meghan B. Azad.
Affiliation
  • Rilwan Azeez; Department of Immunology, University of Manitoba, Winnipeg, MB, Canada. Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
  • Larisa Lotoski; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada. Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canad
  • Aimée Dubeau; Division of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, O
  • Natalie Rodriguez; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada. Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canad
  • Myrtha E. Reyna; Division of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, O
  • Tyler Freitas; Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
  • Stephanie Goguen; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada. Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canad
  • Maria Medeleanu; Division of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, O
  • Geoffrey L. Winsor; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Fiona S. L. Brinkman; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Emily E. Cameron; Department of Psychology, University of Manitoba, Winnipeg MB, Canada.
  • Leslie Roos; Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada. Department of Psychology, University of Manitoba, Winnipeg MB, Canada.
  • Elinor Simons; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada. Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canad
  • Theo J. Moraes; Division of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, O
  • Puishkumar J. Mandhane; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
  • Stuart E. Turvey; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Shelly Bolotin; Centre for Vaccine Preventable Diseases, University of Toronto: Dalla Lana School of Public Health, University of Toronto; Department of Laboratory Medicine and
  • Kim Wright; Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
  • Deborah McNeil; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Strategic Clinical Networks, Alberta Health Ser
  • David M. Patrick; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. British Columbia Centre for Disease Control, Vancouver, BC, Canad
  • Jared Bullard; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada. Cadham Provincial Laboratory, Manitoba Health, Winnipeg, MB, Canada.
  • Marc-André Langlois; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Corey R. Arnold; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Yannick Galipeau; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Martin Pelchat; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Natasha Doucas; CHILD Cohort Study National Parent Engagement Committee
  • Padmaja Subbarao; Division of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, O
  • Meghan B. Azad; Department of Immunology, University of Manitoba, Winnipeg, MB, Canada. Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
Preprint in En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22281242
ABSTRACT
BackgroundThe COVID-19 pandemic is affecting all Canadian families, with some impacted differently than others. Our study aims to 1) determine the prevalence and transmission of SARS-CoV-2 infection among Canadian families, 2) identify predictors of infection susceptibility and severity of SARS-CoV-2 and 3) identify health and psychosocial impacts of the COVID-19 pandemic. MethodsThis study builds upon the CHILD Cohort Study, an ongoing multi-ethnic general population prospective cohort consisting of 3454 Canadian families with children born in Vancouver, Edmonton, Manitoba, and Toronto between 2009-12. During the pandemic, 1462 CHILD households (5378 individuals) consented to participate in the CHILD COVID-19 Add-On Study involving (1) brief biweekly surveys about COVID-19 symptoms and testing; (2) quarterly questionnaires assessing COVID-19 exposure, testing and vaccination status, physical and mental health, and pandemic-driven life changes; (3) in-home biological sampling kits to collect blood and stool. Mean ages were 9 years (range 0-17) for children and 43 years (range 18-85) for adults. Prevalence of SARS-CoV-2 infection will be estimated from survey data and confirmed through serology testing. We will combine these new data with a wealth of pre-pandemic CHILD data and use multivariate modelling and machine learning methods to identify risk and resilience factors for susceptibility and severity to the direct and indirect effects of the pandemic. InterpretationOur short-term findings will inform key stakeholders and knowledge users to shape current and future pandemic responses. Additionally, this study provides a unique resource to study the long-term impacts of the pandemic as the CHILD Cohort Study continues.
License
cc_by
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Cohort_studies / Experimental_studies / Observational_studies / Prognostic_studies Language: En Year: 2022 Document type: Preprint
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Cohort_studies / Experimental_studies / Observational_studies / Prognostic_studies Language: En Year: 2022 Document type: Preprint